A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide

Glioblastoma is the most malignant brain tumor, exhibiting remarkable resistance to treatment. Here we investigated the oncogenic potential of HOXA9 in gliomagenesis, the molecular and cellular mechanisms by which HOXA9 renders glioblastoma more aggressive, and how HOXA9 affects response to chemothe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Pojo, Marta, Gonçalves, Céline S., Xavier-Magalhães, Ana, Oliveira, Ana Isabel, Gonçalves, Tiago, Correia, Sara, Rodrigues, Ana J., Costa, Sandra, Pinto, Luísa, Pinto, Afonso A., Lopes, José M., Reis, Rui M., Rocha, Miguel, Sousa, Nuno, Costa, Bruno M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4480707/
https://ncbi.nlm.nih.gov/pubmed/25762636
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars